STERIS plc STE
208.93
0.16
0.08%
as of 25 Sep
- Market cap
- $20.4B
- P/E
- 25.4×
Follow STE
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
STERIS plc (STE) P/B ratio
As of 25 September 2026, STERIS plc (STE) trades at a P/B ratio of 2.8×. Over the past ten years it has ranged from 1.5× (June 2016) to 7.4× (December 2019); the current reading is higher than 22% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2026 | 3.0× | (10.68%) |
| FY2025 | 3.4× | (2.31%) |
| FY2024 | 3.5× | 10.37% |
| FY2023 | 3.1× | (13.04%) |
| FY2022 | 3.6× | (13.61%) |
| FY2021 | 4.2× | 20.14% |
| FY2020 | 3.5× | 2.62% |
| FY2019 | 3.4× | 40.64% |
| FY2018 | 2.4× | 13.85% |
| FY2017 | 2.1× | 27.82% |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 2.8× | (5.67%) |
| Mar 2026 | 3.0× | (13.13%) |
| Dec 2025 | 3.5× | 0.17% |
| Sep 2025 | 3.5× | 2.24% |
| 42 more quarters | Free account |
Against its own ten years
Low 1.5×
High 7.4×
Ten-year median
3.4×
Current reading's percentile
22
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | 1.4× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 1.4× |
| BIO Bio-Rad Laboratories, Inc. compare | 1.4× |
| PHG Koninklijke Philips N.V. compare | 1.8× |
| SNN Smith & Nephew SNATS, Inc. compare | 2.3× |
| GEHC GE HealthCare Technologies Inc. compare | 2.7× |
| STE STERIS plc | 2.8× |
| PEN Penumbra, Inc. compare | 8.2× |
| DXCM DexCom, Inc. compare | 12.6× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on STE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement